InsidersTradesSigma
Prostatype Genomics AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Prostatype Genomics AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Prostatype Genomics AB has recorded 0 insider filings. Market capitalisation: €23.6m. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 24,263 of 28,017 companies
25.2
score / 100
Value0
Quality50
FCF yld-158%
Earn yld-189%
EV/EBITDA·
ROE-148%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About Prostatype Genomics AB
Prostatype Genomics AB is a company focused on developing genomic tests for prostate cancer. It is listed on the Stockholm Stock Exchange.